{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T21:05:11Z","timestamp":1740171911766,"version":"3.37.3"},"reference-count":15,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T00:00:00Z","timestamp":1744243200000},"content-version":"am","delay-in-days":344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001105"],"award-info":[{"award-number":["UL1TR001105"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","japha.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Pharmacists Association"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.japh.2024.102063","type":"journal-article","created":{"date-parts":[[2024,3,2]],"date-time":"2024-03-02T07:16:48Z","timestamp":1709363808000},"page":"102063","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effect of pregabalin initiation on diuretic requirements in patients with chronic heart failure"],"prefix":"10.1016","volume":"64","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0032-6329","authenticated-orcid":false,"given":"Avital","family":"Basri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4043-7528","authenticated-orcid":false,"given":"Meredith A.","family":"Sigler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin C.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-1286-7794","authenticated-orcid":false,"given":"Dawn H.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.japh.2024.102063_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1365-2125.2008.03196.x","article-title":"Decompensation of chronic heart failure associated with pregabalin in a 73-year-old patient with postherpetic neuralgia: a case report","volume":"66","author":"De Smedt","year":"2008","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.japh.2024.102063_bib4","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cardfail.2006.11.006","article-title":"Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic pain","volume":"13","author":"Murphy","year":"2007","journal-title":"J\u00a0Card Fail"},{"issue":"6","key":"10.1016\/j.japh.2024.102063_bib5","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","article-title":"Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Page","year":"2016","journal-title":"Circulation"},{"issue":"16","key":"10.1016\/j.japh.2024.102063_bib6","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"issue":"18","key":"10.1016\/j.japh.2024.102063_bib7","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA Guideline for the Management of Heart Failure: a Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.japh.2024.102063_bib8","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2217\/fca.15.56","article-title":"Comparative effectiveness of torsemide versus furosemide in heart failure patients: insights from the PROTECT trial","volume":"11","author":"Mentz","year":"2015","journal-title":"Future Cardiol"},{"issue":"1","key":"10.1016\/j.japh.2024.102063_bib9","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12872-019-1112-5","article-title":"Torsemide versus furosemide after acute decompensated heart failure: a retrospective observational study","volume":"19","author":"Rahhal","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"issue":"1","key":"10.1016\/j.japh.2024.102063_bib10","article-title":"Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials","volume":"9","author":"Onakpoya","year":"2019","journal-title":"BMJ, (Open)"},{"issue":"10","key":"10.1016\/j.japh.2024.102063_bib11","doi-asserted-by":"crossref","first-page":"2842","DOI":"10.1111\/jgs.17312","article-title":"Evidence of a gabapentinoid and diuretic prescribing cascade among older adults with lower back pain","volume":"69","author":"Read","year":"2021","journal-title":"J\u00a0Am Geriatr Soc"},{"issue":"10","key":"10.1016\/j.japh.2024.102063_bib12","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1007\/s40264-020-00969-6","article-title":"Use of pregabalin and worsening heart failure: a nationwide cohort study","volume":"43","author":"Lund","year":"2020","journal-title":"Drug Saf"},{"issue":"9","key":"10.1016\/j.japh.2024.102063_bib13","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/pds.4239","article-title":"Pregabalin and heart failure: a population-based study","volume":"26","author":"Ho","year":"2017","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"9","key":"10.1016\/j.japh.2024.102063_bib14","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2459\/JCM.0b013e3282fb7629","article-title":"Possible heart failure exacerbation associated with pregabalin: case discussion and literature review","volume":"9","author":"Page","year":"2008","journal-title":"J.\u00a0Cardiovasc. Med. (Hagerstown)"},{"issue":"8","key":"10.1016\/j.japh.2024.102063_bib15","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1177\/1060028014530551","article-title":"Pregabalin-associated heart failure decompensation in a patient with a history of Stage I heart failure","volume":"48","author":"Fong","year":"2014","journal-title":"Ann Pharmacother"},{"author":"Morgenson","key":"10.1016\/j.japh.2024.102063_bib16"},{"issue":"2","key":"10.1016\/j.japh.2024.102063_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1177\/1074248410388807","article-title":"Prognostic implications of diuretic dose in chronic heart failure","volume":"16","author":"Martins","year":"2011","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"}],"container-title":["Journal of the American Pharmacists Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1544319124000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T02:07:33Z","timestamp":1736302053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1544319124000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":15,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1544319124000839"],"URL":"https:\/\/doi.org\/10.1016\/j.japh.2024.102063","relation":{},"ISSN":["1544-3191"],"issn-type":[{"type":"print","value":"1544-3191"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of pregabalin initiation on diuretic requirements in patients with chronic heart failure","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Pharmacists Association","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.japh.2024.102063","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc. on behalf of the American Pharmacists Association.","name":"copyright","label":"Copyright"}],"article-number":"102063"}}